Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
EWEdwards Lifesciences Corp
| Figure | EWEdwards Lifesciences CorpFY2025 · Dec |
|---|---|
| Revenue | $6.07B |
| Revenue, yoy | +11.5% |
| Net income | $1.07B |
| Net income, yoy | −74.3% |
| Net margin | 17.7% |
| Free cash flow | $1.34B |
| FCF margin | 22.0% |
| EPS, diluted | $1.83 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed